Figure 1From: Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment Study design. *Patients/physicians remained blinded to initial randomized treatment groups until end of open-label period. †Primary endpoint was percent of patients achieving clear or almost clear status on PGA of psoriasis at week 12. BIW: twice weekly; ETN: etanercept; PGA: Physician Global Assessment; QW: once weekly.Back to article page